中文版 | English
Title

Surface-Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo-Photothermal Drugs for Gastric Cancer Theragnostic

Author
Corresponding AuthorLi, Zhijie; Yuan, Yufeng; Wang, Jigang
Publication Years
2023-02-01
DOI
Source Title
ISSN
1616-301X
EISSN
1616-3028
Volume33Issue:7
Abstract
Extracellular vesicles (EVs) are widely used as natural nanoparticles to deliver various cargos for disease diagnosis and therapy. However, unmodified EVs cannot efficiently transport the cargos to desired sites due to non-specific uptake. Here, a delivery system is designed to display nanobodies against cadherin 17 (CDH17) on the surface of EVs isolated from HEK-293 cells and loaded with dye Indocyanine green (ICG) and/or anti-cancer drug dinitroazetidine derivative RRx-001, a blocker for CD47/ signal regulatory protein alpha (SIRP alpha) axis. CDH17 is a promising target for gastric cancer (GC) therapy. In this study, ICG loaded in the EVs engineered with CDH17 nanobodies can realize rapid tumor imaging in a CDH17-positive GC model and can produce significant anti-tumor photothermal therapeutic (PTT) effect after irradiation. Meanwhile, PTT effect can induce immunogenic cell death and macrophage polarization from M2 to M1 phenotype. The engineered EVs loaded with RRx-001 can significantly repress GC tumor growth. Finally, dual loading of ICG/RRx-001 in engineered EVs show maximal anti-tumor efficacy in both cancer cell and patient-derived GC models after only single injection. Collectively, CDH17 nanobody-functionalized EVs loaded with ICG and/or RRx-001 hold great promise to image and treat GC by combining fluorescent dye-induced PTT with chemotherapy.
Keywords
URL[Source Record]
Indexed By
Language
English
Important Publications
NI Journal Papers
SUSTech Authorship
First ; Corresponding
Funding Project
Fundamental Research Funds for the Central Universities[CXPY2022025] ; GuangDong Basic and Applied Basic Research Foundation[2021A1515012164] ; International Science and Technology Cooperation for Shenzhen Technology Innovation Plan[GJHZ20200731095411034] ; Cancer Research and Translational Platform Project of Zhongnan Hospital of Wuhan University[ZLYNXM202004] ; Key Research and Development Program of Hubei Province[2021BCA114] ; Research Fund of the Health Commission of Hubei Province[WJ2021M255] ; National Key Research and Development Program of China[2020YFA0908000] ; Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine[ZYYCXTD-C-202002] ; National Natural Science Foundation of China["82074098","81841001"] ; Shenzhen Science and Technology Innovation Commission["JCYJ20210324115800001","JCYJ20210324114014039"]
WOS Research Area
Chemistry ; Science & Technology - Other Topics ; Materials Science ; Physics
WOS Subject
Chemistry, Multidisciplinary ; Chemistry, Physical ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary ; Physics, Applied ; Physics, Condensed Matter
WOS Accession No
WOS:000935011900034
Publisher
ESI Research Field
MATERIALS SCIENCE
Data Source
Web of Science
Citation statistics
Cited Times [WOS]:0
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/501543
DepartmentShenzhen People's Hospital
Affiliation
1.Southern Univ Sci & Technol, Shenzhen Inst Resp Dis, Shenzhen 518020, Guangdong, Peoples R China
2.Southern Univ Sci & Technol, Jinan Univ, Shenzhen Clin Res Ctr Respirol,Shenzhen Peoples, Affiliated Hosp 1, Shenzhen 518020, Guangdong, Peoples R China
3.Zhongnan Hosp Wuhan Univ, Dept Hepatobiliary & Pancreat Surg, Wuhan 430062, Hubei, Peoples R China
4.Gannan Med Univ, Lab Med, Ganzhou 341000, Jiangxi, Peoples R China
5.Univ Western Australia, Harry Perkins Inst Med Res, QEII Med Ctr, Nedlands, WA 6009, Australia
6.Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia
7.Shanxi Datong Univ, Sch Chem & Chem Engn, Xing Yun St, Datong 037009, Shanxi, Peoples R China
8.Univ Hong Kong, Dept Chem, Hong Kong 999077, Peoples R China
9.Nanchang Univ, Sch Med, Nanchang 330031, Jiangxi, Peoples R China
10.Diakonissen Hosp, Dept Visceral Surg, D-67346 Speyer, Germany
11.China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing 100700, Peoples R China
12.China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China
First Author AffilicationSouthern University of Science and Technology;  Shenzhen People's Hospital
Corresponding Author AffilicationSouthern University of Science and Technology;  Shenzhen People's Hospital;  
First Author's First AffilicationSouthern University of Science and Technology
Recommended Citation
GB/T 7714
Xia, Peng,Yuan, Haitao,Tian, Ming,et al. Surface-Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo-Photothermal Drugs for Gastric Cancer Theragnostic[J]. ADVANCED FUNCTIONAL MATERIALS,2023,33(7).
APA
Xia, Peng.,Yuan, Haitao.,Tian, Ming.,Zhong, Tianyu.,Hou, Rui.,...&Wang, Jigang.(2023).Surface-Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo-Photothermal Drugs for Gastric Cancer Theragnostic.ADVANCED FUNCTIONAL MATERIALS,33(7).
MLA
Xia, Peng,et al."Surface-Engineered Extracellular Vesicles with CDH17 Nanobodies to Efficiently Deliver Imaging Probes and Chemo-Photothermal Drugs for Gastric Cancer Theragnostic".ADVANCED FUNCTIONAL MATERIALS 33.7(2023).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Xia, Peng]'s Articles
[Yuan, Haitao]'s Articles
[Tian, Ming]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Xia, Peng]'s Articles
[Yuan, Haitao]'s Articles
[Tian, Ming]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Xia, Peng]'s Articles
[Yuan, Haitao]'s Articles
[Tian, Ming]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.